Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health related quality of life in Asian patients
出版年份 2023 全文链接
标题
Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health related quality of life in Asian patients
作者
关键词
-
出版物
CURRENT MEDICAL RESEARCH AND OPINION
Volume -, Issue -, Pages 1-10
出版商
Informa UK Limited
发表日期
2023-10-17
DOI
10.1080/03007995.2023.2270894
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized, phase 3 study of second-line tislelizumab versus chemotherapy in advanced or metastatic esophageal squamous cell carcinoma, RATIONALE 302: Asia subgroup.
- (2022) Kuaile Zhao et al. JOURNAL OF CLINICAL ONCOLOGY
- Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer
- (2022) Shun Lu et al. CANCER JOURNAL
- Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life
- (2022) E. Van Cutsem et al. ESMO Open
- Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study
- (2021) J. J. van Kleef et al. Gastric Cancer
- Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
- (2021) Huiyan Luo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Health-related quality of life one year after the diagnosis of oesophageal cancer: a population-based study from the Swedish National Registry for Oesophageal and Gastric Cancer
- (2021) Berit Sunde et al. BMC CANCER
- Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181
- (2021) Antoine Adenis et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient-reported symptoms following diagnosis in esophagus cancer patients treated with palliative intent
- (2020) Laura E Davis et al. DISEASES OF THE ESOPHAGUS
- Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study
- (2020) Jing Huang et al. LANCET ONCOLOGY
- Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
- (2019) Ken Kato et al. LANCET ONCOLOGY
- Global time trends in the incidence of esophageal squamous cell carcinoma
- (2018) Qiao-Li Wang et al. Clinical Epidemiology
- Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis
- (2018) Emil ter Veer et al. EUROPEAN JOURNAL OF CANCER
- Racial Differences in Esophageal Squamous Cell Carcinoma: Incidence and Molecular Features
- (2017) Shirui Chen et al. Biomed Research International
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started